BioTime to Report Fourth Quarter and Full Year 2018 Financial Results on March 14th, 2019

ALAMEDA, Calif.--(BUSINESS WIRE)--lt;a href="" target="_blank"gt;$BTXlt;/agt; lt;a href="" target="_blank"gt;#AMDlt;/agt;--BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that it will report its fourth quarter and full year 2018 financial and operating results on Thursday, March 14th, 2019, following the close of the U.S. financial markets. BioTime management will also host a conference call and webcast on Thursday, March 14th, 2019, at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time to discuss its

Full Story →